Gene · 2829
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,173
Download this page as JSON| Grant | Title | XCR1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA233975 | A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy | 1 | 2023 |
| R01CA236390 | Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response | 1 | 2023 |
| R01CA238471 | B cells in autoimmunity following checkpoint blockade therapy | 1 | 2023 |
| R01DE028351 | ATAD3A as a Novel Target in Head and Neck Cancer | 1 | 2023 |
| R01DE028544 | Mapping the T cell receptor/antigen complex and identifying the genetic-based treatment in Sjogren’s syndrome | 1 | 2023 |
| R01DE030122 | Deep learning for decoding genetic regulation and cellular maps in craniofacial development | 1 | 2023 |
| R01DK117004 | Innate Immunity, Cholesterol, and NASH Pathogenesis | 1 | 2023 |
| R01DK127568 | Role of hepatic Mettl14 pathways in liver metabolism and body metabolic homeostasis | 1 | 2023 |
| R01EB030007 | Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy | 1 | 2023 |
| R01GM084089 | Regulation of alternative cleavage and polyadenylation | 1 | 2023 |
| R01GM134366 | Uncovering how transcription and chromatin 3D structure impact one another during cellular activation | 1 | 2023 |
| R01GM139811 | Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock | 1 | 2023 |
| R01HL129086 | Cardiac Lymphatics in Development and Repair | 1 | 2023 |
| R01HL141853 | CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease | 1 | 2023 |
| R01HL142992 | Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD | 1 | 2023 |
| R01NS058784 | Multimodal approach investigating the immunomodulatory effect ofneural stem cells in stroke recovery | 1 | 2023 |
| R01NS112516 | Alarmin-mediated control of CNS infection | 1 | 2023 |
| R03DE032084 | Role of FAT1 somatic mutations in aggressiveness of head and neck cancer | 1 | 2023 |
| R21AI163421 | Transcriptional basis of embryonic macrophage development | 1 | 2023 |
| R35HG010718 | Functional Genomics: A Phenome-wide Survey | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/grants?page=23